For reference: 50 mg · 5 mL · phosphate-buffered diluent.
I would rather understand the derivation than memorise the outcome.
Two people I asked gave two answers that differ by a factor of ten, which is suggestive.
Can someone walk through the arithmetic step by step?
50 ÷ 5 = 10 mg/mL. Concentration is vial content divided by diluent volume, so 50 mg of peptide in 5 mL of phosphate-buffered diluent gives 10 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.1 mg — 100 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.
Put another way, add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemIf the supplier documentation specifies a diluent, there is usually a reason, and if it specifies nothing, water for injection is the conservative default.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Check the barrel marking, not your memory of it.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
edited 9 Dec 2025 by Dr_Colm_Fitzhenry — added the placebo-arm figures
Read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.
The order of operations matters: temperature first, then diluent measurement, then injection, then gentle dissolution, then labeling.
To be exact about it, a 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.
Do the arithmetic twice, ideally with someone else doing it independently.
This is not exotic. It is just the difference between doing it deliberately and doing it approximately.
Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.
Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.